obesity. Overweight and obesity
Conditions
Interventions
Intervention 1: Intervention group: In this group of people, for 12 weeks, 2 capsules of Synbiotic Femilact Bio Fermentation Co., which contains Lactobacillus rhamnosus, Bifidobacterium lactis, Lactob
Sponsors
Ahvaz University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
30 Years to 50 Years
Inclusion criteria
Inclusion criteria: Body mass index between 30 and 39.99 kg/m2 Willingness to cooperate Female gender Stable weight in the last three months Being in the age range of 30 to 50 years
Exclusion criteria
Exclusion criteria: Pregnancy, breastfeeding and menopause Use of any type of antibiotic in the last 3 weeks Use of weight loss and appetite suppressants Suffering from cancer, cardiovascular disease, diabetes, acute gastrointestinal diseases, infectious diseases, chronic kidney and liver diseases except non-alcoholic fatty liver disease Using any type of food supplement and probiotic products Unwillingness to continue cooperation Death Failure to comply with the intervention (use of less than 90% of supplements) Allergic reaction to Yari supplement
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Body Mass Index. Timepoint: The beginning of the intervention, week 6 and week 12. Method of measurement: Height with the help of a calibrated meter with an accuracy of 0.5 cm, which is connected to the wall at a distance of one meter from the ground level, in such a way that the person is completely attached to the wall from the back, both feet are placed together, and the head is along the ground level and looking The person will be measured straight ahead. People's weight will be measured with the help of a Seka digital scale with an accuracy of 0.5 kg with the lightest clothes and bare feet. The body mass index will also be obtained with the help of placing the value of height and weight in the formula. | — |
Secondary
| Measure | Time frame |
|---|---|
| Waist circumference. Timepoint: The beginning of the intervention, week 6 and week 12. Method of measurement: The circumference of the waist will be measured with the help of a graduated meter with a measurement accuracy of 0.5 cm.;Hip Circumference. Timepoint: The beginning of the intervention, week 6 and week 12. Method of measurement: Hip circumference will be measured with the help of a graduated meter with a measurement accuracy of 0.5 cm.;Waist-Hip Ratio. Timepoint: The beginning of the intervention, week 6 and week 12. Method of measurement: Waist circumference divided by hip circumference.;Fat Mass. Timepoint: The beginning of the intervention, week 6 and week 12. Method of measurement: Body fat will be measured by bioelectrical impedance analysis using inbody x-contact 356 made in South Korea.;Appetite. Timepoint: The beginning of the intervention, week 6 and week 12. Method of measurement: In order to check the state of appetite, the subjects will be asked to indicate the level of appetite, satisfaction and willingness to eat by marking a position along a continuous line between 0 and 100 mm.;Fat Free Mass. Timepoint: The beginning of the intervention, week 6 and week 12. Method of measurement: Fat free mass will be measured by bioelectrical impedance analysis using inbody x-contact 356 made in South Korea.;A Body Shape Index. Timepoint: The beginning of the intervention, week 6 and week 12. Method of measurement: Body shape index is calculated through waist circumference, height and body mass.;Body Adiposity Index. Timepoint: The beginning of the intervention, week 6 and week 12. Method of measurement: An index to estimate body fat, which is calculated using hip circumference and height.;Abdominal Volume Index. Timepoint: The beginning of the intervention, week 6 and week 12. Method of measurement: An index to estimate abdominal fat, which is used to calculate waist circumference and hip circumference.;Conicity Index. Timepoint: The beginning of the inter | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFateme Pakbaz
Ahvaz University of Medical Sciences
Outcome results
None listed